The FcmR receptor for the crystallizable fragment (Fc) of immunoglobulin M (IgM) can function as a cell-surface receptor for secreted IgM on a variety of cell types. We found here that FcmR was also expressed in the trans-Golgi network of developing B cells, where it constrained transport of the IgM-isotype BCR (IgM-BCR) but not of the IgD-isotype BCR (IgD-BCR). In the absence of FcmR, the surface expression of IgM-BCR was increased, which resulted in enhanced tonic BCR signaling. B-cell-specific deficiency in FcmR enhanced the spontaneous differentiation of B-1 cells, which resulted in increased serum concentrations of natural IgM and dysregulated homeostasis of B-2 cells; this caused the spontaneous formation of germinal centers, increased titers of serum autoantibodies and excessive accumulation of B cells. Thus, FcmR serves as a critical regulator of B cell biology by constraining the transport and cell-surface expression of IgM-BCR.
FcµR is a transmembrane receptor initially called 'Fas apoptosis inhibitory molecule 3' (FAIM3 or TOSO) because transfection experiments indicated that this protein protects Jurkat human T lymphocytes from programmed cell death in vitro induced by the death receptor Fas 1-3 . Subsequently, however, several studies identified it as the long-elusive receptor for the Fc portion of IgM that is expressed on the cell surface of human and mouse primary follicular (FO) B cells. Those studies failed to find evidence for a Fas-inhibitory effect on these cells 4, 5 . Therefore, this molecule has been renamed 'FcµR' . Other studies have since confirmed the IgM-binding activity of this receptor [6] [7] [8] .
Surface expression of FcµR has been reported for various leukocyte populations, including granulocytes, macrophages, monocytes, dendritic cells and regulatory T cells. The highest expressions have been noted in B cells [8] [9] [10] . Studies of mice with global FcµR deficiency have suggested that this receptor broadly regulates cellular activation, such as inflammatory responses of dendritic cells and regulatory T cells in autoimmune diseases 10 , the maturation and differentiation of dendritic cells during infection with lymphocytic choriomeningitis virus 11 , and the production of reactive oxygen species by neutrophils 9 . Mice with global deficiency in FcµR also show increased titers of serum IgG autoantibody, as well as increased concentrations of natural serum IgM 6, 7 . The mechanism by which FcµR regulates the homeostasis and autoantibody production of B cells has not been elucidated.
Confocal imaging have suggested that FcµR might also interact with the complex of membrane-bound IgM (mIgM) and the BCR on the B cell surface, where these molecules co-localize 12 . mIgM-BCR consists of mIgM and the associated signaling chains CD79A and CD79B. IgM undergoes extensive post-translational modifications and is sorted in the trans-Golgi network (TGN) for transport to the cell surface 13 . The BCR provides the constitutive, low 'tonic' signaling required for B cell survival 14 . During bone marrow (BM) development, mIgM-BCR signaling regulates B cell selection. Once B cells are mature, antigen encounter by the BCR induces the activation and differentiation of B cells 15 .
In humans, dysregulated expression of FcµR has been associated with various B cell malignancies 16, 17 . On chronic lymphocytic leukemia cells and on HeLa human cervical cancer cells transiently transfected to express FcµR, FcµR internalizes soluble IgM and transports it from the cell surface to the lysosome for degradation, which suggests it might take up IgM-antigen complexes. In such transfected HeLa cells, localization of FcµR is detected not only on the cell surface and following internalization in the lysosomes but also in the TGN 16 . This indicates that the mIgM-FcµR interaction might also occur in the TGN during the development of B cells.
Indeed, through the use of high-resolution microscopy and proximal-ligation assays, we demonstrated that FcµR interacted directly with mIgM in the TGN of immature B cells and that this interaction regulated the surface expression of BCRs and thereby regulated tonic BCR signaling. The lack of FcµR-mediated suppression of the surface expression of BCR, and therefore BCR signaling, in the B cells of mice with B-cell-specific deficiency in FcµR resulted in dysregulated A r t i c l e s spontaneous activation and differentiation of B-1 and B-2 cells and the development of a lymphoproliferative disorder. Our data support a model whereby FcµR constrains BCR expression to regulate the fundamental homeostasis and biology of B cells.
RESULTS

FcmR surface expression on B cells
Consistent with published reports 4, 7, 8, 18 , the highest surface expression of FcµR was on B cells, but such expression was mostly absent on CD4 + or CD8 + T cells ( Supplementary Fig. 1a,b) . Myeloid-cell populations, such as Gr-1 + cells (granulocytes), CD11b + F4/80 + cells (macrophages) and CD11c + cells (dendritic cells), had low surface expression of FcµR (Supplementary Fig. 1a,b) . mRNA-expression analysis confirmed Fcmr expression by all peripheral B cell subsets; it was highest in splenic FO B cells (CD19 + IgD hi CD23 + ) and splenic B-1 cells (CD19 hi IgM hi IgD lo CD23 − CD43 + ) and was somewhat lower in marginal-zone (MZ) B cells (CD19 + CD21 hi CD23 − ) and in peritonealcavity B-1 cells (Fig. 1a) . Protein-expression analysis confirmed high surface expression not also by splenic B-1 cells but also by MZ B cells ( Fig. 1b and Supplementary Fig. 1c ). Surface expression of FcµR seemed to be low in the peritoneal cavity ( Fig. 1b and Supplementary  Fig. 1c ). FO B cells in the spleen had higher FcµR expression than that of FO B cells in the inguinal lymph nodes ( Fig. 1b and Supplementary  Fig. 1c ). Thus, FcµR was dynamically regulated in various B cell subsets and by tissue location.
During BM development, FcµR expression occurred first at the late pre-B cell stage, with rapidly increasing expression among immature B cells (Fig. 1c,d and Supplementary Fig. 1d ). Confocal microscopy confirmed expression of FcµR on the surface of B220 + CD43 − IgM lo−pos IgD − immature B cells ( Fig. 1e) . However, we also noted an unexpected strong intracellular presence of FcµR ( Fig. 1e) . Two-color confocal microscopy of primary immature B cells for the integral membrane protein TGN38 indicated that FcµR localized to the TGN (Fig. 1e) . The TGN has a central role in post-translational modifications and the sorting of mIgM for transport 13, 19 . This suggested that FcµR might interact with mIgM during B cell development, when IgM is modified and is first transported to the cell surface. Together these data demonstrated correlated expression of FcµR and mIgM during the transition from the late pre-B cell stage to the immature B cell stage. In developing B cells, FcµR was present in two distinct compartments that included the cell membrane and the TGN.
Interaction of FcmR with secreted and membrane IgM
To study the direct effects of the IgM-FcµR interaction in B cells, we created mice with B-cell-specific deficiency in the gene encoding FcµR (Fcmr) through use of the Cre recombinase-lox system, A r t i c l e s ( Supplementary Fig. 1a ) and gene-expression analysis ( Fig. 1f) Fig. 2a ). Furthermore, there was no difference between Fcmr flx/flx Cd19-Cre + mice and the control mice in the rate at which they accumulated immature CD93 + B cells in the spleen at 12 d after sublethal irradiation ( Supplementary  Fig. 2b,c) .
As has been shown before 4, 16, 20 , secreted IgM (sIgM) can bind to the surface of B cells. As expected, genetic ablation of FcµR reduced the binding of sIgM to B cells in vitro ( Fig. 2a and Supplementary Fig. 3a) , which we tested by exposing purified spleen B cells from control and Fcmr flx/flx Cd19-Cre + mice to purified and biotinylated sIgM. The binding of sIgM to the B cell surface was rapidly lost ( Supplementary  Fig. 3a,b) , suggestive of rapid internalization. T cells did not bind to sIgM ( Supplementary Fig. 3b (Fig. 2b) . The CD19 + IgD b B cells from Fcmr flx/flx Cd19-Cre + mice bound significantly less sIgM a than did B cells from control mice, as indicated by their lower mean fluorescence intensity of IgM a staining (Fig. 2b,c) . In-vivo-bound sIgM was lost as rapidly in culture as after incubation with sIgM in vitro (Supplementary Fig. 3c ). In contrast, and unexpectedly, B cells from Fcmr flx/flx Cd19-Cre + mice stained more intensely for mIgM-BCR (IgH b ) than did their counterparts from control mice ( Fig. 2c,d) . Thus, FcµR facilitated the in vivo binding of natural IgM to the surface of B cells and seemed to be also involved in the surface expression of IgM-BCR.
Immunoprecipitation studies have demonstrated that FcµR can directly bind to and interact with IgM 4,12 . To distinguish the interactions of FcµR with the membrane and secreted forms of IgM, we first conducted stimulated emission-depletion (STED) microscopy, which provides resolution of two proteins down to 50 nm in living cells 21 .
To differentiate between mIgM and sIgM, we isolated B cells from mixed-BM irradiation chimeras, which we generated by adoptive transfer of BM from wild-type (IgH b ) mice and sIgM-deficient (Ighm tm1Che ; called 'sIgM −/− ' here) (IgH a ) mice into lethally irradiated C57BL/6 recipients. B cells from sIgM −/− mice lack the µ s exon, which encodes the secreted form of IgM, but they express mIgM 22 . In these chimeras, all sIgM was therefore derived from the IgH bexpressing wild-type B cells. Staining for IgD with an allotypespecific monoclonal antibody identified the immunoglobulin genotype of FO B cells (data not shown), such that analysis of IgD a -expressing sIgM −/− cells distinguished the expression of mIgM (IgM a ) from the binding of sIgM (IgM b ) directly ex vivo. The exquisite specificity of the monoclonal antibodies to IgM a (DS.1) and to IgM b (AF6.78.25) is well known [23] [24] [25] and was further demonstrated by us ( Supplementary Fig. 4a-c) . Analysis of FO B cells revealed that mIgM a was expressed evenly on the cell surface, whereas sIgM b was more focally spaced ( Fig. 2e) . sIgM was also present in vesicles directly beneath the cell membrane, but mIgM was not ( Fig. 2e,f) , consistent with the reported internalization of sIgM into endosomes 16 . Direct ex vivo visualization of the internalization of sIgM by splenic FO B cells ( Fig. 2e ,f) suggested that this was an ongoing process. FO B cells lacked measurable mIgM in intracellular compartments ( Fig. 2e,f) , probably due to the low turnover rate of mIgM 26 .
Next we used three-color confocal microscopy of FO B cells from the mice studied above to investigate the co-localization of FcµR with mIgM and/or sIgM. On the cell membrane, FcµR co-localized with both mIgM and sIgM ( Fig. 2f) , while there was little if any such co-localization in the TGN (Supplementary Fig. 5a ). In contrast, STED microscopy of immature B cells showed that FcµR co-localized with IgM both on the cell membrane and in the TGN (Fig. 2g,h and Supplementary Fig. 5b) . The intracellular co-localization was strongly focal and vesicular, with individual vesicles containing both FcµR and IgM in close proximity to the cell membrane ( Supplementary  Fig. 5b) , suggestive of transport.
To provide further evidence of interaction between FcµR and mIgM, we used a proximity-ligation assay based on the antigen-binding fragment Fab (Fab-PLA) with a resolution of 10-20 nm (ref. 27) . Strong Fab-PLA signals, indicative of protein-protein interactions, were detected in the cytosol of saponin-treated B220 + CD43 − CD25 − IgD − immature BM B cells in a subcellular region that stained with the Golgi marker lectin-GSII-Alexa Fluor 488 ( Fig. 2i and Supplementary Fig. 5c ). The FcµR-mIgM interaction also occurred on the cell surface (stained for the ganglioside GM-1, with cholera toxin subunit B conjugated to fluorescein isothiocyanate) of intact immature B cells, albeit A r t i c l e s to a lesser extent ( Fig. 2i) . In contrast, splenic mature FO B cells displayed only weak FcµR-mIgM interactions and only on the cell surface ( Fig. 2j and Supplementary Fig. 5c ). Together these studies revealed strong interactions between FcµR ad IgM in the TGN of immature B cells and much weaker interactions on the surface of mature B cells. A r t i c l e s
Constraint of BCR surface expression by FcmR
The TGN of primary B cells contains mIgM but not sIgM 16, 19 ; thus, FcµR might affect the transport of mIgM. Flow cytometry showed that B cells from Fcmr flx/flx Cd19-Cre + mice and those from control (Fcmr flx/flx Cd19-Cre − ) mice had similar staining for total surface IgM ( Fig. 3a) . However, separate staining for sIgM binding and mIgM expression after transfer of either control or Fcmr flx/flx Cd19-Cre + (IgH b ) B cells into IgH a host mice revealed that the higher expression of mIgM by Fcmr flx/flx Cd19-Cre + B cells was offset by diminished surface binding of sIgM, which masked any differences in IgM-BCR expression ( Fig. 2b,c) . That was confirmed by the transfer of FO B cells from either Fcmr flx/flx Cd19-Cre + mice or control mice into B-cell-deficient mice. While staining for total IgM (sIgM and mIgM) was similar before cell transfer (Fig. 3a) , at 72 h after cell transfer, greater surface staining of IgM was seen on B cells from Fcmr flx/ flx Cd19-Cre + mice than on those from control mice (Fig. 3b) , presumably because the bound sIgM was internalized, which would leave only surface mIgM. Consistent with that, expression of the immunoglobulin α-chain (CD79A) was significantly higher in Fcmr flx/flx Cd19-Cre + B cells than in control B cells (Fig. 3c) . The higher mIgM expression by Fcmr flx/flx Cd19-Cre + B cells was not due to alterations in gene transcription (Fig. 3d) . These data suggested that the interaction with FcµR in the TGN of developing immature B cells constrained the transport of mIgM and/or its retention on the cell surface.
To provide evidence of FcµR-mediated regulation of the transport of mIgM, we expressed chimeric immunoglobulin µ-chains (IgM) linked to green fluorescent protein (GFP) either alone or as chimeric IgM-BCR together with the signaling subunits CD79A and CD79B (Fig. 3e) in an S2 Drosophila cell system 28 . As expected, only a fully assembled IgM-BCR was placed on the cell surface, and its amount was significantly lower after co-expression of FcµR ( Fig. 3f,g) . The expression of IgD linked to the red fluorescent protein mCherry in IgD-BCR ( Fig. 3e) was not altered when it was co-expressed with FcµR either in different cells or in the same cell ( Fig. 3f,g) . To determine whether FcµR affects the transport of IgM-BCR, we measured the re-appearance of IgM-BCR GFP fluorescence after photobleaching on the surface of the transfected S2 cells (Fig. 3h,i) . The mobile-fraction and half-time recovery data showed that the reappearance of IgM-BCR fluorescence was significantly reduced in the presence of FcµR, while IgD-BCR expression was not affected (Fig. 3h,i) . We concluded that FcµR directly and specifically restricted the transport of IgM-BCR to the surface of developing B cells.
Enhanced tonic BCR signaling in Fcmr flx/flx Cd19-Cre + B cells Surface BCR expression is required for B cell survival, and the amount of surface BCR influences both B cell development and mature B cell reactivity. Therefore, we determined next whether increased surface expression of mIgM by Fcmr flx/flx Cd19-Cre + B cells affected steady-state or 'tonic' BCR signaling. Tonic BCR signaling triggers phosphorylation of phosphoinositide 3-OH kinase (PI3K) and its downstream targets, including the kinase Erk, the GTPase Ras and the kinase Akt 29, 30 . The transcriptional repressor Foxo1 is a major target of Akt phosphorylated at Ser473, in tonic BCR signaling 29 . De-repression of the Foxo1 target Cdkn1b (which encodes the cellcycle inhibitor p27) can lead to the entry of FO B cells into the cell cycle 29, 31 . Foxo1 also controls cell survival, in part via repression of Bcl2l11 (which encodes the cellular stress sensor and pro-apoptotic factor Bim, a member of the Bcl-2 family) 29, 32 .
Expression of the regulatory subunit (p85) and the catalytic subunit (p110) 33 of PI3K was significantly higher in B cells from Fcmr flx/flx Cd19-Cre + mice than in those from the control mice (Fig. 4a,b) , as was the abundance of phosphorylated Akt in purified B-2 and B-1 cells (Fig. 4c,d) . B-1 cells had more phosphorylated Akt than did B-2 cells in control and Fcmr flx/flx Cd19-Cre + mice (Fig. 4d) . Heightened tonic BCR signaling of B-1 cells is consistent with their increased autoreactive repertoire 34, 35 . Phosphorylated Btk was also greater in abundance in B-1 and B-2 cells freshly isolated from Fcmr flx/flx Cd19-Cre + mice than in those from control mice (Fig. 4e,f) , and increased phosphorylated Akt and phosphorylated Btk were seen in Fcmr −/− B cells derived from chimeras established with BM from mice with global deficiency in Fcmr than in those from chimeras established with BM from wildtype C57BL/6 mice ( Supplementary Fig. 6a,b) . Cre-related toxicity was not responsible for differences in phosphorylation, as increased PI3K and phosphorylated Akt were observed only in Fcmr flx/flx Cd19-Cre + mice and not in Fcmr wt/flx Cd19-Cre + mice, Fcmr wt/flx Cd19-Cre − mice or Fcmr flx/flx Cd19-Cre − mice (Supplementary Fig. 7a,b) . A good correlation existed between the amount of phosphorylated Akt and phosphorylated Btk in B cells and the surface expression of IgM on those cells ( Fig. 4g and data not shown). This correlation was stronger for B cells from Fcmr flx/flx Cd19-Cre + mice than for those from control mice, presumably because IgM staining labels the BCR only in Fcmr flx/flx Cd19-Cre + B cells, while in control B cells, it labels both mIgM and sIgM; the latter probably does not affect BCR signaling. The data suggested that the stronger signaling in Fcmr flx/flx Cd19-Cre + B cells was a direct outcome of the enhanced expression of mIgM.
Assessment of the expression of mRNA from four Foxo1 target genes showed the expected difference in Fcmr flx/flx Cd19-Cre + B cells relative to control cells, all indicative of enhanced tonic BCR signaling. Expression of Cdkn1b and Bcl2l11 was significantly lower in the absence of FcµR, while Aicda (which encodes the cytidine deaminase AID and is upregulated by activation of Foxo1) was significantly higher in the absence of FcµR (Fig. 4h) . Rag1 (which encodes the recombinase component RAG-1) was not expressed in B cells from either control mice or Fcmr flx/flx Cd19-Cre + mice (Fig. 4h) . These data indicated that FcµR regulated tonic BCR signaling by constraining surface expression of mIgM during B cell development.
To determine whether the absence of FcµR affected the B cell response to crosslinking of the BCR, we compared the responses of purified FO B cells from control and Fcmr flx/flx Cd19-Cre + mice to stimulation with antibody to IgM (anti-IgM). Both phosphorylated Akt and B cell proliferation were similar in these cultures (Fig. 4i,j) . However, consistent with the ex vivo results, Fcmr flx/flx Cd19-Cre + B cells had more phosphorylated Akt than did control B cells in the absence of stimulation after culture (Fig. 4j) . Consistent with their reduced expression of Bcl2l11 (which encodes the pro-apoptotic A r t i c l e s regulator Bim), in vitro cultures of Fcmr flx/flx Cd19-Cre + B-1 and B-2 cells showed enhanced survival relative to that of control B-1 and B-2 cells (Fig. 4k,l) . That survival advantage was lost after stimulation with anti-IgM, anti-IgM plus anti-Fas, or lipopolysaccharide (Fig. 4k,l) .
Thus, the absence of FcµR and the resulting increases in BCR expression enhanced tonic BCR signaling and B cell survival while not significantly affecting signaling after strong crosslinking of the BCR mediated by anti-IgM. Regulation of natural IgM and autoantibody production by FcmR Increased BCR expression and the resulting increases in tonic BCR signaling are expected to affect B cell homeostasis. Indeed, the concentration of sIgM in serum from Fcmr flx/flx Cd19-Cre + mice was twice that in serum from their control (Fcmr flx/flx Cd19-Cre − ) counterparts (Fig. 5a) , similar to those reported for mice with global Fcmr deficiency 6, 7 , while IgA concentrations were similar in Fcmr flx/flx Cd19-Cre + mice and their control counterparts, and IgG concentrations were consistently but not significantly higher in Fcmr flx/flx Cd19-Cre + mice than in their control counterparts (Fig. 5b,c) . As an explanation for the higher serum IgM concentration, the frequency of IgM-secreting cells in spleen and BM was also much greater in Fcmr flx/flx Cd19-Cre + mice than in their control counterparts (Fig. 5d) . In addition, the IgM spot sizes in ELISPOT assays seemed to be bigger for Fcmr flx/flx Cd19-Cre + samples than for their control counterparts (Fig. 5d) . The frequency of cells secreting IgG without stimulation in vitro was also greater in Fcmr flx/flx Cd19-Cre + mice than in their control counterparts (Fig. 5e) , and titers of IgM and IgG directed against double-stranded DNA (anti-dsDNA) were significantly higher in Fcmr flx/flx Cd19-Cre mice + than in their control counterparts ( Fig. 5f,g) , as has also been seen in mice with global Fcmr deficiency 7, 8 . However, after normalization of autoantibody concentration to total immunoglobulin concentration, the amount of IgM anti-dsDNA relative to that of total IgM was diminished rather than elevated (Fig. 5f) , while the amount of IgG anti-dsDNA relative to that of total IgG remained elevated (Fig. 5g) . Together the data demonstrated that direct FcµR signaling suppressed the development of natural IgM-producing cells and IgGautoantibody-producing cells in a B-cell-intrinsic manner. FcµR has been shown to inhibit apoptosis mediated by Fas and its ligand FasL in T cell lines transfected to express FcµR 3 . We found that Fas-induced cell death in vitro was measurable only in cultures of Fcmr flx/flx Cd19-Cre + B-1 and FO B cells but not in their control counterparts (Fig. 4k,l) . This apparent inhibitory effect of FcµR on Fas-mediated killing directly correlated with a higher frequency and absolute number of Fas-expressing CD38 lo PNA + germinal-center B cells in the spleen of Fcmr flx/flx Cd19-Cre + mice, relative to that in their control counterparts (Fig. 5h,i) . Notably, the enhanced tonic BCR signaling observed seemed to lead to increased spontaneous B cell activation and germinal-center formation (Fig. 4a-h) , a likely source of the increased autoreactive serum IgG titers (Fig. 5g) . The apparent protection from Fas-induced cell death in the presence of FcµR observable in vitro thus seemed to be due mainly to the suppression of spontaneous B cell activation and, therefore, reduced expression of Fas. That conclusion was further supported by the finding that Fas-induced cell death in vitro reduced the frequency of surviving Fcmr flx/flx Cd19-Cre + B cells only to the frequency seen for their control counterparts (Fig. 4k,l) .
Natural IgM is important for early immunological protection against bacteria and viruses such as influenza virus 24, 36, 37 . Consistent with the elevated baseline concentration of total serum IgM in these mice, the concentration of natural IgM that bound influenza virus strain A/Puerto Rico 8/34 (A/PR8) was significantly higher in Fcmr flx/flx Cd19-Cre + mice than in control mice before exposure to the virus (Fig. 5j) . The greater abundance of natural IgM in Fcmr flx/flx Cd19-Cre + mice than in control mice before infection and at day 1 after infection with A/PR8 (Fig. 5k,l) correlated with their better early control of viral loads of influenza virus in the lungs (Fig. 5m) . We concluded that FcµR expression in B cells not only reduced the concentration of protective natural IgM in serum but also controlled potentially harmful autoreactive IgG.
Enhanced B-1 cell activation in Fcmr flx/flx Cd19-Cre + mice Increased BCR signaling leads to enhanced development of B-1 cells, a population largely responsible for the production of natural IgM 35 . As expected from their increased serum IgM concentrations, Fcmr flx/flx Cd19-Cre + mice showed a considerably higher frequency and number of splenic B-1 cells, particularly CD5 + B-1a cells, than that of their control (Fcmr flx/flx Cd19-Cre − ) counterparts ( Fig. 6a and Supplementary  Fig. 7c ), while the frequency and absolute number of such cells in the peritoneal cavity were similar ( Fig. 6b and Supplementary Fig. 7d ). The number of BM B-1 cells was also higher in Fcmr flx/flx Cd19-Cre + mice than in their control counterparts, although this result did not reach statistical significance (Fig. 6c) . Fcmr flx/flx Cd19-Cre − , Fcmr wt/flx Cd19-Cre − and Fcmr wt/flx Cd19-Cre + mice had B-1 cell populations similar to those of wild-type mice (Supplementary Fig. 7c ). We concluded that FcµR regulated the activation of B-1 cell and the secretion of natural IgM by regulating BCR expression.
To determine whether Fcmr-deficient B-1 cells were responsible for the increased IgM production in Fcmr flx/flx Cd19-Cre + mice, we generated neonatal immunoglobulin-allotype chimeras in which only B-1 cells (IgH b ) lacked expression of Fcmr, while all BM-derived B cells were wild-type (IgH a ). These mice were generated by the treatment of neonatal wild-type (IgH a ) mice, from birth to 6 weeks after birth, with anti-IgM a , for the deletion of all endogenous B cells, followed by transfer into these mice, shortly after birth, of allotype-mismatched cells obtained by washout of the peritoneal cavity of Fcmr flx/flx Cd19-Cre + mice, as a source of B-1(IgH b ) cells that reconstituted the B-1 cell compartment of the recipient mice. The recipient mice were analyzed no earlier than 2 months after end of antibody treatment, when the number of endogenous B-2 (IgH a ) cells had returned to normal, but the number of B-1 cells had not control chimeras were reconstituted with cells (IgH b ) from the peritoneal cavity of A r t i c l e s to that of control chimeras, but the frequency of Fcmr flx/flx Cd19-Cre + B-1 cells was at least double that in spleen and BM (Fig. 6d) . Moreover, Fcmr flx/flx Cd19-Cre + B-1 cells developed about twice as many CD138 + plasma cells as B-1 cells did in the control chimeras (Fig. 6e) , and the frequency of B-1-cell-derived IgM b -secreting cells was significantly higher in chimeras given Fcmr flx/flx Cd19-Cre + cells than in control chimeras (Fig. 6d) , while, as expected, the frequency of IgM-secreting B-2 cells (IgM a , and thus wild-type) was comparable in these chimeras (Fig. 6f) . The frequency of IgM-secreting B-1 cells (IgM b ) were more than twofold higher in chimeras given Fcmr flx/flx Cd19-Cre + cells than in control chimeras, as measured by ELISPOT assay (Fig. 6f) . Consequently, the serum IgM concentration generated by Fcmr flx/flx Cd19-Cre B-1 cells (IgM b ) was substantially higher than that generated by control B-1 cells (Fig. 6g) . A r t i c l e s Analysis of chimeras generated by the reconstitution of lethally irradiated B-cell-deficient (µMT) mice with peritoneal-lavage cells from Fcmr flx/flx Cd19-Cre + (IgH b ) mice or wild-type C57BL/6 (IgH b ) mice, as a source of B-1 cells, and BM cells from wild-type (IgH a ) mice, as a source of B-2 cells, yielded results similar to those obtained for the neonatal immunoglobulin-allotype chimeras reported above ( Supplementary  Figs. 8 and 9 ). We concluded that increased BCR signaling in Fcmr flx/flx Cd19-Cre + B-1 cells intrinsically controlled the production of natural 
A r t i c l e s
IgM by enhancing differentiation of the cells into IgM-secreting cells in the spleen and BM, probably after stimulation by autoantigens.
B-2 cell lymphocytosis in Fcmr flx/flx Cd19-Cre + mice
The enhanced IgG autoantibody production in Fcmr flx/flx Cd19-Cre + mice suggested that direct FcµR signaling also regulates the BMderived B cell compartments. MZ B cells are negatively regulated by strong BCR signaling 38 . Consistent with findings obtained for one mouse line with global Fcmr deficiency 6,7,20 but not for another such line 8 , we found a significantly lower frequency of splenic MZ B cells in Fcmr flx/flx Cd19-Cre + mice than in control (Fcmr flx/flx Cd19-Cre − ) mice, while the frequency of the FO B cell compartment seemed to be largely unaffected (Fig. 7a) . However, when we took total numbers of splenocytes into account, we found that the total MZ B cell pool in Fcmr flx/flx Cd19-Cre + mice was actually similar to that of their control counterparts, while the number of splenic FO B cells was increased in these mice (Fig. 7a) .
We also noted significant enhanced cell cycling and cell survival in Fcmr flx/flx Cd19-Cre + mice, relative to that of that of their control counterparts; specifically, they had a greater frequency of cycling Ki67 + B cells and total number of dividing B-1 and B-2 cells, as measured by incorporation of the thymidine analog BrdU (Fig. 7b,c) . Fcmr flx/flx Cd19-Cre + mice also yielded fewer dead (7-AAD + ) B-1 and B-2 cells (Fig. 7d) . These data explained the finding that as early as 3 months of age, Fcmr flx/flx Cd19-Cre + mice showed significantly greater spleen cellularity and spleen enlargement, relative to that of that of their control counterparts (Fig. 7e,f) , and by 8 months, they had pronounced splenomegaly with expanded follicular compartments, as assessed histologically (Fig. 7g) .
DISCUSSION
This study has revealed a previously unknown function for FcµR: control of the abundance of IgM-BCR on the B cell surface and thereby regulation of tonic BCR signaling. The extensive interaction of FcµR with mIgM identified here in the TGN of developing B cells and its inhibitory effect on the accumulation of mIgM on the cell surface suggested that FcµR exerted its control by regulating the transport of mIgM. FcµR has thus been identified as a critical regulator of B cell homeostasis.
The reported dysregulated expression of FcµR in various human B cell malignancies further underscores its importance in shaping the balance between constraining B cell responses to self and foreign antigens and promoting such responses, as well as for the support of B cell survival and rapid clonal expansion in response to pathogens. The lymphoproliferative disorder that developed in Fcmr flx/flx Cd19-Cre + mice over time was reminiscent of human leukemic mantle-cell lymphoma, diffuse large B cell lymphoma, follicular lymphoma, marginal-zone lymphoma and Hodgkin's lymphoma, in which a lack of FcµR expression has been reported 16 . Notably, FcµR is overexpressed in other lymphomas, such as chronic lymphocytic leukemia, a malignancy of IgM + B cells. The upregulation of FcµR might be an attempt by the cells to constrain chronic B cell activation and B cell population expansion in patients with such diseases. Although we did not observe malignant transformation of B cells in mice, this might have been due to the relatively short lifespan of mice relative to that of humans. Notably, there have been no previous reports of lymphoproliferative disorders in the three published mouse strains with global FcµR deficiency 1, 7, 8 . Further work will be needed to determine whether expression of FcµR on cells other than B cells might also indirectly affect B cell activation.
The FcµR-mediated control of BCR expression and signaling limited the protective capacity of B-1 cells by reducing the concentration of natural IgM. Increased production of natural IgM has been reported in mice with global Fcmr deficiency 6, 7 . Our studies demonstrated the B-cell-intrinsic nature of this regulation and identified fully differentiated CD138 + splenic B-1 cells as the source of this increased protective IgM. Thus, while the reduction in tonic IgM-BCR signaling mediated by FcµR limited B cell activation and autoantibody production by B-2 cells 7, 8 , it also constrained the protective capacity of B-1 cells.
Both sIgM −/− mice and Fcmr −/− mice generate autoantibodies 20, 39 , which might indicate that sIgM-FcµR interactions regulate autoantibody production. The underlying mechanisms of autoantibody production in these two genetically altered mice, however, seem to be distinct. sIgM −/− mice have extensive alterations in B cell development, starting as early as at the pro B cell-pre-B cell transition 20 , before substantial FcµR expression and changes in the repertoire of the developing B-1 and B-2 cells. Those changes result in larger numbers of anergic and autoantibody-producing B-2 cells, an increased MZ B cell compartment and a nearly complete loss of peritoneal B-1 cells but not of splenic B-1 cells 20 . In contrast, B cell development seemed to be unaffected in Fcmr flx/flx Cd19-Cre + mice, and the B-2 cell repertoire showed no major differences in the use of immunoglobulin heavy-chain variable regions (data not shown). In further contrast to sIgM −/− mice, Fcmr flx/flx Cd19-Cre + mice had increased B cell pools with a reduced, not increased, frequency of MZ B cells, as well as expanded, rather than reduced, B-1 cell pools. Thus, the effect on B cell homeostasis differs considerably for mice lacking sIgM versus those lacking FcµR. That would support our conclusion that the regulation of B cell development by FcµR was due mainly to its intracellular interactions with mIgM and, thus, control of BCR expression, rather than to its interaction with sIgM on the B cell surface. Our data suggest a plausible scenario in which mildly autoreactive peripheral B cells that had escaped tolerance induction in Fcmr flx/flx Cd19-Cre + mice experienced chronically enhanced tonic BCR-signaling via autoantibody binding and/or by enhanced BCR auto-aggregation, due the greater abundance of cellsurface IgM-BCR. This might result in the development of spontaneous germinal centers induced by autoantigens, class-switch recombination and increased production of IgG autoantibodies.
While enhanced B cell responsiveness in Fcmr flx/flx Cd19-Cre + mice caused spontaneous germinal-center formation and autoantibody production, exposure to influenza virus induced germinal centers of normal size that followed the normal kinetics of induction and involution (data not shown). Differential regulation of germinal centers induced by self antigen and those induced by foreign antigen has also been seen for other mouse models of autoimmune disease 40, 41 . B cells from Fcmr flx/flx Cd19-Cre + mice showed spontaneous activation, despite normal expression of IgD-BCR. Published studies have suggested that IgM-BCR is superior in responding to monovalent antigens, whereas IgD-BCR requires polyvalent antigens 42 . The data might suggest that tonic BCR signaling is induced mainly by binding to monovalent antigens mediated by IgM-BCR, while stimulation by highly multivalent foreign antigens and/or pathogens effectively activates IgD-BCR, which is unaffected by FcµR deficiency.
While our study focused on the FcµR-mIgM interaction in the TGN, by generating mixed-BM irradiation chimeras of sIgM −/− and allotype-mismatched wild type mice, we distinguished the interaction of FcµR with mIgM and sIgM ex vivo. Our data provide an image of B cells continuously taking up sIgM, which then accumulated in endosomal compartments 16 . Given the self-reactive repertoire of natural IgM, this uptake might result in the continued presentation of self antigens to T cells and might help with ongoing tolerization of the T cell compartment 43 . In support of that proposal, germinal centers spontaneously developed in Fcmr lx/flx Cd19-Cre mice, which
